SBI Securities’s NeuroOne Medical Technologies NMTC Stock Holding History

SBI Securities’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13	Hold	13	–	–	﹤0.01%	3978
2026 Q2	$40	Buy	13 +10	+333%	+$41	﹤0.01%	3721
2026 Q1	$16	Hold	3	–	–	﹤0.01%	3792
2025 Q4	$15	Hold	3	–	–	﹤0.01%	3822
2025 Q3	$18	Hold	3	–	–	﹤0.01%	3933
2025 Q2	$14	Buy	+3	New	+$11	﹤0.01%	3966

Other funds holding NMTC

Princeton Global Asset Management Princeton, New Jersey $692M AUM 20.31% 1-Year Est. Return

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

SBI Securities's NMTC Position: Q3 2026 in Review

SBI Securities held its NeuroOne Medical Technologies (NMTC) position steady in Q3 2026 at 13 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #3978.

SBI Securities first reported a position in NMTC in Q2 2025 and has held it in 6 quarters since. The position peaked at $40 in Q2 2026. 3 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

SBI Securities held 13 shares of NeuroOne Medical Technologies worth $13 as of Q3 2026.
SBI Securities left its NeuroOne Medical Technologies share count unchanged in Q3 2026.
NeuroOne Medical Technologies made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3978 holding.
SBI Securities first reported a position in NeuroOne Medical Technologies in Q2 2025 and has held it in 6 quarters since.
SBI Securities's NeuroOne Medical Technologies position peaked at $40 in Q2 2026.
3 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.